Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles

CannabisNewsWire Editorial Coverage: Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative.

This seems possible when one considers the truly innovative work being done in the sector by the likes of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile), which has developed a patented delivery technology with disruptive potential, delivering 475% more CBD to the bloodstream after 15 minutes than conventional formulations. Other sector innovators are making a similar impact, including the likes of noted cannabinoid biopharma GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) and that of researchers and product developers Tilray Inc. (NASDAQ: TLRY), MariMed Inc. (OTCQB: MRMD) and Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB).

CBD is going mainstream into all kinds of consumer goods and foodstuffs.
Hard data on numerous health benefits appears to be core driver behind growing CBD acceptance.
$1 billion-plus cannabis edibles segment growing rapidly but separate from CBD market.
Innovative delivery tech could revolutionize the industry and consumer receptivity.

To view an infographic of this editorial, click here.

Mainstream CBD Teeing Up an Edibles Boom

The recent May 9 report from leading cannabis industry analysts BDS Analytics and Arcview Market Research forecasts that the market for nonpsychoactive cannabinoid CBD (cannabidiol) alone will hit upwards of $20 billion by 2024, running at a CAGR around 49%. With last year’s farm bill legalizing industrial hemp in the United States, CBD sales in dispensaries have been rapidly increasing. Additionally fueled by an explosion of CBD-infused edibles, it appears that conservative sector growth estimates from analysts such as New York-based investment bank Cowen & Co. may be shortsighted.

A mounting, positive consumer sentiment about the health benefits of cannabinoids is broadly underscored by the work of developers such as GW Pharmaceuticals, whose CBD-based Epidiolex is already FDA-approved to treat two types of severe childhood epilepsy. CBD is going mainstream, with high-profile celebrities such as iconic homemaker Martha Stewart publicly coming out in support of the numerous health benefits that CBD is said to have, like lowering stress and anxiety or battling inflammation and pain. It is little wonder that consumers are seeing CBD used as a nutraceutical additive in everything from over-the-counter cosmetics and pet health products, to wildly popular edibles infused with CBD oil.

The cannabis edibles segment is also interesting to many analysts, and recent forecasts such as the Arcview Group’s $4.1 billion by 2022 figure brings into stark relief the immense potential of a market that already ballooned to more than $1 billion last year. BDS Analytics predicts that the same rapid CBD product sales growth seen at dispensaries will continue to occur as the majority of sales shift to general retail stores. An increasingly receptive consumer base is seen driving this trend, as roughly 66% of hemp-derived CBD consumers in the United States now believe in full federal legalization of cannabis in general.

The demand for CBD products now appears to be nothing short of historic, with CPG (consumer packaged goods) companies having never witnessed such an insatiable appetite for a new product type before. CBD, THC and others of the 100 or more cannabinoids found in cannabis appear to show strong potential for gobbling up market share across massive, vulnerable consumables industries, ranging from soft drinks and snack foods to alcoholic beverages and pet aides.

Revolutionary Delivery Technology Could Supercharge Edibles Industry

Unfortunately, the vast majority of edible CBD is being delivered to the human body in an inefficient manner, with most of the CBD simply ending up in the toilet. Typical CBD-infused products utilize industry-standard delivery methods such as MCTs (medium-chain triglyceride) like coconut oil. Such MCTs are a somewhat crude but straightforward approach, offering a rich texture and “mouth feel” but promising only limited delivery of CBD. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM) patented formulations have considerable disruptive potential amid the ongoing CBD boom, with recent multi-objective animal studies showing a clear advantage over industry standards, in terms of how efficiently edible forms of cannabinoids enter the bloodstream.

The company’s standard DehydraTECH formulation using LCFAs (long-chain fatty acids) went head-to-head with a concentration-matched MCT formulation in the recently announced animal studies, yielding a whopping 475% higher CBD blood concentration level — and at four times the speed (15 minutes). These days, it is not uncommon to see people throwing around terms such revolutionary or groundbreaking willy-nilly. So when a technology comes along that truly does represent a fundamental paradigm shift, it can easily get lost in the ceaseless 24-hour news cycle cacophony.

Those words may truly apply here. Lexaria’s patented LCFA formulation has demonstrated a stunning 334% higher average maximum CBD blood concentration level over a 60-minute interval than standard MCT oil formulation, with initial onset (measurable CBD in blood) occurring three times faster (as little as only two minutes), a key factor for edibles.

This animal-study data is compelling and establishes a solid foundation under LXRP’s value proposition to investors. That proposition become even more interesting considering that LXRP is the only company in the United States with such a powerful absorption and delivery technology backed up by proven claims in lab, animal and even human clinical studies. DehydraTECH appears to deliver more CBD, more quickly, than virtually any other brand or technology available in the country.

In a recent human clinical study conducted at a medical research university, DehydraTECH-enabled capsules branded as TurboCBD delivered 317% more CBD into the human bloodstream than did generic CBD lacking this impressive technology. Seemingly, the human testing in addition to animal reinforces the notion that the industry may be witnessing a revolutionary breakthrough.

No Brag, Just Facts

Consider what this technology could mean for the CBD edibles space. At 15 minutes, the DehydraTECH formulation achieved 475% higher concentrations and to levels not seen or achieved by MCT. This puts DehydraTECH on par with inhalation in terms of how fast acting it is, something which has been a brass ring to the edibles industry for many years.

Rapid uptake by the body’s various tissue systems as opposed to valuable raw ingredients being flushed down the toilet because of minimal absorption — that is a huge selling point to consumers. And DehydraTECH technology provides the additional benefit of enabling lower drug-dosage quantities, an important point to consider given that “Lexaria has every reason to believe that virtually identical results would have been achieved if THC was instead the cannabinoid under examination [in the aforementioned animal studies], consistent with subjective human clinical studies Lexaria’s partners have conducted with edible THC products.”

Another great feature of LXRP’s proprietary technology is that it eliminates bad tastes typically found in CBD oils, thus eliminating the need for large quantities of sugar or artificial sweeteners to mask the taste, making the ingredient even more attractive to health-conscious consumers.

CBD Companies Leading the Charge

Cannabis is going mainstream, with CBD appearing to lead the way.

GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) has the enviable distinction of developing Epidiolex, one of the most widely known CBD indications ever devised. Made world famous by coverage of the drug’s use in combatting severe childhood epilepsy, the drug is the first prescription, FDA-approved, plant-derived cannabinoid medicine in the United States and has acted as a kind brand ambassador for CBD in general.

Tilray Inc. (NASDAQ: TLRY) has grown into quite an operation, with a presence in eight countries across four continents, and worldwide production capacity that is on track to hit 1.3 million square feet this year. A strategic partnership with Authentic Brands Group is expected to have co-branded CBD products hitting consumers throughout ABG’s vast North American distribution network in the second half of this year. And Tilray even managed to beat first-quarter sales expectations, having posted a 195% jump in year-over-year revenues to $23 million, on the strength of factors such as solid hemp-food sales growth from the recently acquired Manitoba Harvest.

MariMed Inc. (OTCQB: MRMD) recently announced the formation of a wholly owned subsidiary to be entirely focused on hemp-derived CBD products. MariMed Hemp Inc. will have its own dedicated executive team, proprietary brand and product lines, as well as distribution and marketing relationships. A bold move for this multistate operator of licensed cannabis facilities, which has an increasingly strong presence in branded cannabis and hemp product lines, as well as a retained initial core business providing advisory services.

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) recently made a huge announcement with entry into a multiyear, multimillion-dollar agreement with mixed martial arts organization UFC to conduct hemp-derived CBD research on athlete recovery and wellness at UFC’s substantial Las Vegas institute site. This high-profile and well-capitalized initiative could pave the way for sweeping clinical studies to more thoroughly evaluate CBD across the gamut of current major target indications such as pain management, inflammation, injury/exercise recovery and mental well-being.

Lexaria’s DehydraTECH continues to offer hardline absorption data that makes it one of the most exciting names in CBD delivery technology today. As the CBD industry continues to build momentum approaching widespread, mainstream acceptance and inevitable incorporation into a multiplicity of everyday consumers products and foods, LXRP stands poised to profit mightily.

For more information on Lexaria Bioscience Corp., visit Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Celebrity Attention Fuels Rising Press Profile of CBD

CannabisNewsWire Editorial Coverage: Companies with a presence in the CBD market are seeing their profiles rise, thanks to growing media and celebrity attention.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD store. Tilray Inc. (NASDAQ: TLRY) has seen strong market coverage as its shares rose following action to tackle product shortages in Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has fostered its public profile through efforts by the company’s media-savvy co-CEO. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) drew attention as its share value rose with a large external investment. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) has been focusing on growing better CBD-producing plants, work that has drawn attention to its VP of cultivation.

Kim Kardashian’s CBD-themed baby shower drew attention to the range of relaxing CBD products.
Other high-profile appearances are boosting upper-end CBD brands.
Broad media coverage is normalizing and drawing customers to the sector.

To view an infographic of this editorial, click here.

CBD Whips Up Media Storm

Recent months have seen CBD in the media spotlight more than ever before. The relaxing natural compound, derived from hemp and cannabis plants but without the psychoactive qualities of THC, has been grabbing attention across the internet and in print and broadcast media. What was a fringe interest only a few years ago has now grown into the subject of huge mainstream attention.

Some of the coverage comes in news and opinion pieces, where the recent legalization of hemp in the United States has driven a surge in interest. But with CBD products on sale in a growing number of shops across a growing number of states, attention has also come from fashion and lifestyle writers. Even celebrities are in on the act, with CBD products appearing in the hands of the rich and famous — a seemingly sure omen of popularity in the media age.

Garnering Celebrity Support

One of the brands that has benefited strongly from this flurry of media attention is Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a creator of health and wellness products. Headquartered in Vancouver, British Columbia, Wildflower has reached out of Canada and into the United States as North America has become increasingly hospitable to CBD products. The company is focused on building brands around plant-based products, appealing to those looking for natural way to relax and be healthy.

CBD is an important part of Wildflower’s stable of brands. Its Wildflower Wellness brand provides capsules, tinctures, vaporizing liquid and other CBD-infused products, all designed to support relaxation, health and wellness. With its combination of effectiveness and natural products, the brand is, like many others in the CBD sphere, designed to appeal to those looking to escape the stresses of modern life.

That’s presumably how Wildflower products came to appear at Kim Kardashian’s recent baby shower. Kardashian and her husband, Kanye West, recently welcomed their fourth child — and second born by surrogate. In preparation for the event, Kardashian threw an extravagant and well-reported baby shower. To help her guests escape the stresses of life and to prepare her celebrate the “calm before the baby storm,” the celebrity themed her baby shower around the relaxing power of CBD. The event included such tranquil activities as massages, flower arranging and mixing CBD oils to create personalize shower gifts.

As part of the event, Kardashian encouraged her guests to enjoy a relaxing puff of CBD, and Wildflower’s vaporizing products were on hand to provide this opportunity. A Wildflower vaporizer appeared in pictures from the party, as celebrities made the most of what CBD has to offer.

This isn’t the first time that Wildflower products have found their way into celebrity hands. Wildflower goods were selected for inclusion in the 2019 Four Seasons Hotel Hollywood Swag Bags, given to nominees, presenters and actors staying at the hotel for this year’s Oscars. With CBD becoming not just acceptable but fashionable, Wildflower was a natural fit for a hotel wanting to make a good impression on its celebrity guests.

The image of CBD as a prestigious, high-profile consumer luxury has been further reinforced by the creation of a CBD shop within the shop at Saks Fifth Avenue. Directly connecting CBD with other high-end brands and the concept of luxury shopping, this move firmly stakes out CBD’s place within the luxury goods market. And once again, Wildflower is visible among the products on display.

Media Eyes Up CBD

This move into the celebrity culture and the high-end shopping market has come alongside growing media attention for CBD brands.

The arrival in Los Angeles of prominent Long Island beauty boutique Botanica Bazaar gave Vogue reason to cover a range of products including CBD tinctures. For this part of the article, the magazine focused on Wildflower’s products. The company’s strongest CBD remedies, its tinctures have been designed to counter one of the big problems with cannabinoid products — the sometimes unpleasant taste. Wildflower has tackled this challenge by adding natural flavorings to create a product that’s recognized for its flavor as well as its relaxing qualities.

The Vogue piece garnered positive coverage for CBD in general, with Botanica Bazaar’s owners talking about how the pain-relieving power of these products had won a growing number of loyal customers. The article also provided positive coverage for Wildflower, with the writers noting that “Wildflower’s CBD tinctures and vapes not only kill the aesthetics game, but also taste good.”

Coverage of broader cannabis culture has brought CBD brands to the attention of a receptive audience. When Vice presented an article on the best female-owned brands in the cannabis sector, the magazine included Wildflower in a section on pain-relieving spa products. A pain-relief product designed to tackle muscle, joint and back pain, the CBD+ Healing Stick was recommended in the article as a useful cure for period pain.

Buzzfeed went so far as to publish an article on why readers should be buying CBD Christmas gifts for everyone, including featuring recommendations for products their readers might want to pick. These included a lip butter, truffles and CBD-infused sparkling water, showing the wide range of options now available to the CBD consumer.

Wildflower once again stole some of the limelight. The company’s disposable CBD vaporizer pen proved too good a novelty to leave out of the selection. All in all, the company has received mention in more than 15 different articles and media pieces, touting Wildflower products and singing the praises of CBD in general.

CBD’s Growing Press Presence

It seems like hemp and CBD can’t help but make news.

Canadian company Tilray Inc. (NASDAQ: TLRY), a world leader in the field of cannabis and cannabinoids, hit the headlines in Investor’s Business Daily after it announced its stock had jumped based on first-quarter sales. Like many companies in Canada, Tilray has been struggling to meet demand following the legalization of recreational cannabis. However, the company has responded swiftly to the supply shortage, investing $32.6 million to expand it cultivation and manufacturing space by nearly 20%, a move that should keep its profile high.

Another of the big cannabis companies, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has built up its profile partly through the work of co-CEO Mark Zekulin. The more outward-facing of the company’s two CEOs, Zekulin has courted public attention through media appearances such as a recent interview with Market Watch. The fact that Canopy Growth is one of the biggest cannabis companies in one of the biggest cannabis markets doesn’t hurt either. This drew the attention of drinks giant Constellation Brands, which invested billions in the company with an eye to products such as CBD drinks; the move made headlines across the business world. A push into the United States with a new hemp-growing facility in New York state has further raised the company’s public profile.

Some of the media coverage around cannabis and CBD has an air of incredulity to it. When Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) saw its share price rise despite first-quarter losses, it inevitably drew attention from market commentators. An investment of C$2.4 billion from tobacco giant Altria is undoubtedly a major factor in the company’s strong performance despite setbacks. Such investments promise future developments, and market commentators watch eagerly to see what will happen next.

Within the United States, CBD producer Charlotte’s Web Holdings Inc. (OTC: CWBHF) (CSE: CWEB) has gained attention as a business with an unpretentious brand and a strong scientific grounding to its products. Using proprietary genetics, the company is working to produce high-quality, low-cost hemp to meet the demands of an increasingly large market. Charlotte’s Web has also won attention for its vice president of cultivation, Jared Stanley, who was recently featured in a list of the hundred most influential figures in the cannabis industry.

As CBD’s cultural presence grows, companies with a strong media presence and the attention of celebrities seem certain to benefit.

For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Hemp Companies Move to Tackle CBD Shortfall

CannabisNewsWire Editorial Coverage: A boom in demand for cannabidiol (CBD) has created an alarming shortage, which savvy hemp companies are aggressively looking to solve.

Cultivation supplies company Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has acquired several other suppliers, allowing it to benefit from economies of scale. Canadian cultivator Tilray Inc. (NASDAQ: TLRY) is investing heavily in new growing space. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has expanded from Canada into the United States and is collaborating with other companies to meet demand. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a substantial inflow of funds from a tobacco company and is investing some of it in R&D. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is focusing on growing high-quality hemp to supply a range of novel products.

To view an infographic of this editorial, click here.

Demand for CBD has soared thanks to consumer interest.
Legalization nationally in the United States through the farm bill has led to more cultivators and a rising demand for cultivation supplies.
Companies are rising to meet these supply challenges through expansion, consolidation and innovation.

CBD and the Challenge of Demand

The ability to meet customer demand is one of the fundamental challenges for any industry. If businesses can’t keep up with demand, they don’t just miss out on an immediate opportunity for profit, they risk losing the attention of customers in the long term.

For a relatively new product such as CBD, that problem is particularly acute. Though demand for the product is currently high, the industry is not well established, making it critical that companies reinforce customer habits through supplying the products they’re seeking. Being new, however, makes the supply problem particularly challenging, as production techniques and supply pipelines are not fully developed for massive consumption. The future of the industry will depend upon which companies are able to meet this demand and how they do it.

The CBD Boom

The CBD industry has seen a staggering boom in the past. This growth has created opportunities for companies such as brand expansion and acquisition firm Sugarmade Inc. (OTCQB: SGMD), which is making a strong play into the sector, as well as new companies focused purely on CBD.

The demand for CBD is easy to explain. Recent research into its uses has suggested that this naturally occurring compound can be useful in a range of health and well-being roles, including managing pain and helping users to relax. This compelling research has naturally drawn the attention of customers seeking new options to improve the way they feel, especially those consumers who prefer to avoid heavily processed chemicals.

Publicity around CBD has further raised demand. Some of this attention comes from emerging CBD companies, whose marketing efforts have raised the profile not just of their own brands but of the sector as a whole. Additional exposure has come from the battle to make hemp cultivation legal across the United States. Because hemp provides most of the available CBD, this process also brought hemp production into the public spotlight. Companies such as Sugarmade found their businesses attracting far more attention — so more demand.

This demand culminated with the passage of the 2018 Farm Bill. Signed into law just before Christmas, the bill legalized the production of hemp on a national level. This makes hemp production a far more straightforward and reliable source of income, and will allow more farmers to benefit from a profitable cash crop. As companies rush to enter the sector or expand production in response to the bill, demand for the services and equipment they need has soared. As a provider of the hydroponic cultivation supplies on which many hemp farmers depend, Sugarmade and its pending acquisition subsidiaries — AthenaUnited.com and Zenhydro.com — has found itself swamped with orders.

Shortage of CBD

This surge in demand following the farm bill has created an undeniable opportunity within the CBD sector — along with a challenge. Fortunately for Sugarmade, it’s a challenge that they appear to be instrumental in solving.

Hemp cultivators are currently unable to provide the volume of plants that customers want. One of the reasons is that the cultivation, processing and supply systems simply aren’t large enough. The CBD industry was already on an expansion path as it tried to meet growing demand before the farm bill. Now with that demand growing further, it’s going to take time and a big push to achieve what people are after. Making an industry legal doesn’t make it magically appear.

Then there’s the unreliability of the CBD levels in hemp. The chemical content of the plants is small and hugely variable. Relatively small shifts in the makeup of a crop can have a significant impact on how much CBD is produced.

Cultivating larger, more reliable crops is vital to the future of the industry. Manufacturers are eager to rise to that challenge. However, to do so they need to get the supplies to get them off the ground, including hydroponic systems, feed chemicals and the clippings, or clones, from which much hemp is grown.

Looking at the effect of this shortage in just one state, Sugarmade CEO Jimmy Chan was optimistic about the effect on his company. “With at least 42,000 acres of hemp expected to be planted in Kentucky and considering an average plant density per acre of well over 1,000, farmers in Kentucky will need hundreds of millions of clones over the coming years,” he said. “When these numbers are multiplied over the many other hemp cultivation states, it is easy for anyone to see the strong demand scenario that is quickly developing.”

Responding to the Shortage

To meet the demand for CBD, hemp cultivators will clearly need to improve both the quantity and the quality of their crops.

It’s easy to see how an increase in quantity will have knock-on effects for suppliers such as Sugarmade. The company’s pending acquisition subsidiaries AthenaUnited.com and ZenHydro.com are seeing orders for their cloning supplies skyrocket, with backorders building up as they rush to meet unprecedented demand.

The search for more reliable levels of CBD is also contributing to this demand. Hydroponic systems give cultivators control over the growing process. By experimenting with hydroponics and controlling the light, plant food and environment, cultivators can find ways to grow plants with predictable and higher levels of CBD. This experimentation will create even more demand for hydroponic materials. Sugarmade should be central to the improvement of these processes.

To provide supplies as efficiently and profitably as possible, Sugarmade has gone through a period of expansion, acquiring other companies in the hydroponics and CBD sector. This model of consolidation is being repeated across the industry as businesses seek efficiencies of scale.

“Sugarmade plans to integrate these businesses fully as soon as is possible, making us one of the larger suppliers to this growing marketplace,” stated Chan. “Additionally, we are in process of vetting other possible acquisitions to further enhance our portfolio of hydroponic and cultivation supply products. We are certainly excited about our prospects for the remaining part of this year and into next year.”

Expanding Potential

Sugarmade isn’t the only CBD-related company using acquisitions to expand potential. Canadian company Tilray Inc. (NASDAQ: TLRY) has undertaken a series of acquisitions, including Manitoba Harvest, the world’s largest hemp foods company, to strengthen its position in hemp. The company has responded decisively to the recent supply shortage in hemp and related plants in North America, in part by investing $32.6 million to significantly expand it production space across three sites, increasing its cultivation and manufacturing footprint by nearly 20%.

Another of the big Canadian companies, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has opted into investing south of the border thanks to the farm bill. The company has set up a hemp-growing facility in New York state and acquired another hemp company, AgriNextUSA. Canopy Growth has also been collaborating with other CBD and related companies to boost their shared output. One collaboration with PharmHouse has seen Canopy Growth provide high-quality genetic stock to PharmHouse’s growing facility. In return, Canopy Growth will benefit from an offtake agreement to obtain flowers from the plants PharmHouse is growing.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has benefited from attention on the sector through a huge injection of outside cash. Tobacco giant Altria has agreed to invest C$2.4 billion in Cronos Group, providing the company behind Marlboro with a way into a new sector. Fittingly, Cronos Group is investing some of its funds in a new R&D facility that will work on vaporizer products. Vaping has become a popular way of consuming CBD, so the investment may allow Cronos to benefit from the market from multiple angles.

American CBD producer Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) has been using proprietary genetics to work toward the goal of high-quality, low-cost hemp. The company has also been creating innovative new products to make use of the growth in CBD. Its recently expanded pet line offers the promise of calming dogs and easing joint pain brought on by age.

Rising demand for CBD has created a challenge, but it’s a challenge that smart companies are definitely ready to meet.

For more information on Sugarmade, visit Sugarmade Inc. (OTCQB: SGMD)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Next Stage Cannabis Stocks in the Spotlight

CannabisNewsWire Editorial Coverage: Projections for the cannabis markets are staggering, yet there’s evidence that the lofty estimates may be understated.

Cannabis projections often fall far short of actual sales growth.
Cannabis-infused beverages looks to be next area of explosive upside.
Beverage and cannabis companies striking deals to gain market access.
New technologies could snag significant market share.

Once viewed as wild conjecture for the future of cannabis markets, forecasts in 2015 fell severely short of actuality. At that time, consensus was that Canada could reach CA$2.8 billion in legal sales by 2020. Sage prognosticators now say that the market may exceed CA$7 billion in 2019. Catering to the tastes of market demographics, intense interest is now focused on the cannabis-infused beverages market. Not even legal in Canada until this fall, the infused beverage market is already pegged to reach a mind-boggling CA$4.4 billion within five years.

Joining the ranks of the majors to meet this titanic demand, Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (SRUTF Profile) announced a joint venture with Moosehead Breweries, the largest and oldest independent beer company in Canada. Cannabis colossus Tilray Inc. (NASDAQ: TLRY) announced a research partnership into infused beverages and is bringing in executives with backgrounds in the beverage industry. The maker of Corona and Modelo beer increased its stake in Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) to 38%, spurring speculation of cannabis-infused beverages to come. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) entered a joint venture with Molson Coors Canada to produce CBD-infused beverages. And New Age Beverages Corp. (NASDAQ: NBEV) is anticipated to begin roll out of Marley+CBD-infused drinks in four targeted U.S. states.

To view an infographic of this editorial, click here.

Untapped Market

Soothsayers seem to consistently underestimate the warp-speed of public acceptance and the velocity of uptake of cannabis products. As marijuana muscles into the mainstream, usage among all age groups is on the upswing. However, among the most coveted 18-34 demographic, there’s an explosion of acceptance as these users mature in a world where cannabis is common. Millennials are about three times and Gen Z about four times more likely to use cannabis than aging Boomers. Forward-leaning cannabis companies are full throttle in product and brand development to corral this coveted demographic and capture market share, now and for decades to come.

According to a United Nations report, cannabis is the most widely consumed drug on the planet. Even so, only about 4% of the world’s adult population has used it. North America, the leader in cannabis growth, is only the fourth largest cannabis consumer market on the globe, ranking behind Asia, Africa and Europe in sheer size of its cannabis consumer market. As public perceptions change and legalization expands, the number of users is certain to skyrocket in a nearly untapped market. A global transition is underway and presenting a once-in-a-generation opportunity.

The Deal

Of particular interest is the cannabis-infused beverages market. Poised to capture an outsized share of the infused beverage boom, Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) and Moosehead announced a joint venture that marries Moosehead’s vast adult-beverage experience with Sproutly’s innovative cannabis technology. The result? A fast-onset, fast-offset option that some have called the industry’s holy grail of beverages.

Leveraging Sproutly’s transformational technology to create the world’s first and only truly natural water-soluble cannabinoids, the partners will develop, produce and market beverages that will solve the major issues that limit the consumer appeal of cannabis-infused beverages in the market today: 1) a beverage that actually tastes good and 2) that can provide the cannabis experience with an immediate onset and controllable experience of up to 90 minutes. Sproutly and Moosehead intend to be ready to put recreational infused beverages on the shelves by the time of legalization.

Utilizing Sproutly’s acquired patent-pending process, validated by 13 years of scientific R&D, the partners will form a new company to launch a full line of infused products. Moosehead is an iconic Canadian brand, selling more than 140 million bottles of beer annually across Canada, the U.S. and 15 countries around the world. The company’s 152 years of beverage experience and formulation prowess has led to over a dozen popular brands, including licensed and supporting partner brands such as Angry Orchard, Twisted Tea and Samuel Adams beer, proving the ability to manufacture and market leading adult beverages. In addition, the Oland family who owns 100% of Moosehead also owned the beer brand Alexander Keith’s prior to its sale to Labatt Brewery Company which is currently owned by Anheuser-Busch InBev.

Unlike other lopsided joint venture forays into cannabis beverages, the Sproutly-Moosehead agreement is a 50-50 equity partnership structured to maximize the alignment of interests. Even the board of directors will have an equal number of board members from each company, with Sproutly appointing the chairman. The joint venture includes a five-year exclusive agreement for Sproutly to deliver its breakthrough water-soluble cannabis solution, and Moosehead will license all its brands and related intellectual property to the new company formed by the agreement. Moosehead will provide marketing, distribution, logistics, admin and other resources while Sproutly will deliver formulation, R&D, marketing and other resources.

Underscoring the significance of the agreement, Matthew Oland, a Moosehead executive and scion of the founders, will leave Moosehead to become CEO of the newly formed company. Moosehead and Sproutly combined appear to be going all in on this enterprise.

Paradigm Shift

Perplexing problems plague the creation of ingestible cannabinoids. Cannabinoids and terpenes are completely insoluble in water resulting in serious difficulties with absorption, dosing, efficacy and onset/offset times. For years laboratory-formulated cannabinoids have been engineered to become water compatible and sort of mimic water solubility. These techniques have been in use by pharmaceutical and beverage companies for decades, but production challenges and insolubility issues remain for cannabinoids. Relying on the same outdated, costly and ineffective techniques, these encapsulation and emulsion technologies are what’s currently being employed by the suitors to the cannabis-infused beverage bonanza.

Establishing a paradigm shift in how cannabis is effectively and efficiently processed, delivered and consumed, Sproutly is transcending the industry’s current antiquated regimens. Already a licensed premium cannabis producer with 1,400 kg annual production capacity, Sproutly also owns the rights to the world’s first and only naturally water-soluble cannabis technology for Canada, Australia, Jamaica, Israel and the entire European Union.

Sproutly’s partner who licensed the technology, Infusion Biosciences, discovered that the cannabis plant naturally produces water-soluble forms of phytochemicals. Infusion Biosciences then created a patent-pending Aqueous Phytorecovery Process (APP) for the recovery of naturally water-soluble phytochemicals (Infuz₂O). Unlike encapsulation or emulsion, Infuz₂O is a truly water-soluble cannabis solution that fully dissolves in water and can be easily and economically added directly into beverage formulations.

Infuz₂O has the unique ability to deliver precise doses and measurable amounts of cannabis and is predictable, with less than five minutes onset and less than ninety minutes offset times, the same as smoking or vaping cannabis. Sproutly’s APP Technology also recovers valuable natural oil-based cannabinoids in addition to the water-soluble phytochemicals destined for beverages. Sproutly’s transformational technology produces the world’s only naturally water-soluble bioactive molecules that deliver the full experience of cannabis that is strain specific. Product and production advantages such as these could lead to a lion’s share of a market set to quickly balloon to billions of dollars.

Creating Value

Highly scalable, Sproutly’s pioneering technology is also an extremely cost-effective process to extract both water-soluble and naturally derived oil-based cannabinoids. Using its APP technology, Sproutly should be able to produce better quality products faster and cheaper than the competition. Little wonder Moosehead is so committed. Current methods require at least four complex processes to extract cannabis oil from biomass and three more to obtain water-compatible products.

In just two steps, using APP technology, Sproutly produces both water-soluble and oil-based cannabinoids without using any alcohol or solvents. And that’s not all. Using current CO₂ extraction methods, THC recovery rate is about 60%. Sproutly’s APP Technology delivers a total of 90% THC recovery rate. The economic ramifications seem obvious. This isn’t an idea or concept; the technology is in place. In fact, the APP Technology is already proven in real-world applications and is ready for full operational deployment.

Shortly after acquiring Infusion Biosciences Canada and the rights to use the APP technology, Sproutly entered an exclusive technology license agreement with Micronutrient Technologies to produce nutritional minerals in water solutions in a low-cost, scalable process. The agreement provides Sproutly the unique ability to add healthy, water-soluble minerals such as calcium, magnesium, iron and zinc, and in different combinations, directly into various cannabis beverages without artificial chemical additives. Sproutly now has the unequaled ability to create beverages that not only cater to cannabis consumers but also cross over to the large, functional beverage market. Sproutly’s seemingly unparalleled versatility in beverage formulation crosses multiple sectors with limitless end-user applications.

The joint venture with Moosehead not only validates Sproutly’s technology but also positions the venture to reap enormous rewards in the nascent cannabis-infused market. And this may only be the beginning for Sproutly.

In the Hunt

Tilray Inc. (NASDAQ: TLRY) is one of the established cannabis companies in the hunt for the infused-beverage market. In December, the company announced a research partnership with Anheuser-Busch. Tilray also recently announced that it was bringing executives into its leadership team who have strong backgrounds working for big beverage companies.

Focused on healthy beverages, New Age Beverages Corp. (NASDAQ: NBEV) is banking on the popularity of Bob Marley to help grow its products. The company’s Marley+CBD products will first begin roll out in four U.S. states, although a date hasn’t been established for when that will happen.

Last August, Constellation Brands, the maker of Corona and Modelo beer, increased its stake in Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) to 38%, spurring speculation of cannabis-infused beverages to come. Canopy’s forays into the U.S. hemp markets suggest CBD beverages may be on the horizon.

HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) entered a joint venture with Molson Coors Canada (MCC) last summer to produce CBD-infused beverages in which the brewing giant took 57.5% ownership. The new company will be led by a former Molson Coors executive. As part of the deal, HEXO issued 11,500,000 warrants to MCC.

There’s little argument where the cannabis markets are headed, and all indications point to infused beverages becoming the next big surge. Perhaps the lofty forecasts for the cannabis-infused beverages market in Canada will imitate past cannabis projections and vastly exceed expectations again.

For more information on Sproutly Canada, visit Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

The Cannabis Bonanza Has Just Begun

CannabisNewsWire Editorial Coverage: The cannabis industry presents a rare opportunity to profit from spectacular growth in a virtually untapped market.

Legal marijuana market projected to reach $146.4 billion.
United States and Canada current epicenter of cannabis growth.
Brand recognition and retail reach imperative for market share.

Capturing market share and creating long-term success in this explosive market will require brand recognition and retail reach. Shortly after posting its tenth consecutive quarter of increased revenues, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) announced intentions to further expand its footprint with the acquisition of premier licensed cannabis retailer, City Cannabis Corp. A finalized accretive acquisition will add significant revenues to Wildflower, providing access to several valuable cannabis licenses in lucrative premium locations. Other companies in the sector are looking to grow in the market through other promising ways. Tilray Inc. (NASDAQ: TLRY) recently acquired Natura Naturals Holdings, boosting capacity to supply cannabis products across Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) bought hemp company AgriNextUSA to accelerate entry into key American jurisdictions. Medmen Enterprises Inc. (OTCQX: MMNFF) (CSE: MMEN) announced the purchase of two vertically integrated operations, which include retail locations and 25,000 square feet of cultivation and production capacity. And only two weeks ago, Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) completed the acquisition of Eureka to provide access to California’s wholesale market through a large greenhouse facility.

To view an infographic of this editorial, click here.

Market Frenzy

The sweeping growth of the cannabis industry is rooted at least in part from a groundswell of public support that has turned into a tidal wave of acceptance. Fifteen years ago, only a third of Americans supported federal legalization of marijuana. About two-thirds of Americans now support legalization, up from only 54% two years ago. Among adults under age 35, a whopping 85% favor federal legalization. The movement gained so much momentum so fast that the industry is scrambling to keep up. As the cannabis industry and markets mature, acquisition and consolidation deals appear to be all but certain.

The global legal marijuana market, valued at $9.3 billion in 2016, is expected to reach $146.4 billion by the end of 2025, an incredible 16-fold increase over nine years. Legal cannabis markets are still a relatively new phenomenon, and the market is nowhere near its total sales potential. An estimated 272 million global consumers use cannabis, equivalent to only about 4% of the world’s population. Growth trajectory is virtually vertical. Perhaps nowhere is this hyper-growth more spectacular than North America. Wall Street’s top cannabis analyst forecasts the U.S. market to grow to $80 billion by 2030 assuming national availability.

B.C. Center of Boom

Cannabis demand is even greater north of the border. The industry has been struggling with cannabis supply shortages ever since recreational cannabis was legalized across Canada. The country’s westernmost province, British Columbia, is no exception. The B.C. market registered a little over CA$19 million in legal cannabis sales in 2018, but that number is expected to explode to CA$722 million in annual sales by 2024 — a mind-boggling 37-fold increase over six years.

Pegged to soar nearly 3,700% in the next six years, British Columbia is ground zero for cannabis growth. Headquartered at the epicenter of this upsurge, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) has already staked out an enviable market position and is further expanding its retail footprint and product distribution in the province. The company recently announced that it intends to acquire City Cannabis Corp. in an all-stock deal.

Holding two of the three City of Vancouver licenses to sell cannabis, City Cannabis is a premier cannabis retailer and the only company with multiple licenses in British Columbia. The Letter of Intent looks to solidify Wildflower’s position as a high-profile retail outlet of premium brands generating millions in revenues right in the heart of the B.C. cannabis boom.

“City Cannabis and Wildflower are the perfect combination of premier products and a premier consumer retail experience,” said Wildflower CEO William MacLean. “City Cannabis’ retail consumer data and insight will help shape development of Wildflower’s product line-up while the retail expertise of City Cannabis will aid Wildflower in its retail expansion. The combination of Wildflower and City Cannabis will form a truly global cannabis company.”

Born in British Columbia, Wildflower now has a retail reach that extends from Vancouver to Los Angeles and New York. Established in 2012, Wildflower Brands is constantly expanding development, design, marketing and retail distribution of its branded products in the cannabis sector. The company launched into Washington State in 2016 and has been on a tear ever since.

Creating a Global Brand

Today Wildflower now markets its distinctive CBD+ products to more than 300 retailers in the health and wellness space and operates in regulated cannabis markets throughout North America in accordance with jurisdictional regulations for THC and CBD+ products. Wildflower’s unique and holistic products are developed and manufactured at the company’s U.S.-based GMP facilities, tested by a third-party lab and backed by a 100%-satisfaction guarantee.

Each Wildflower product is synergistically formulated to create a unified global wellness brand. For example, Wildflower’s highly recognized Wildflower Wellness brand offers a broad array of hemp-based, full-spectrum, CBD-infused products from vaporizers and capsules to tinctures, soaps and topicals.

The company’s King Recharge is on the cutting edge of cannabis technology and delivery systems with its King Extracts, a sleek, rechargeable vaporizer offering five popular CBD strains and a unique pocket-sized charging and storage case.

Closely associated with select hospital oncology departments, Exclusive is Wildflower’s Los Angeles-based dispensary of premium cannabis products. Wildflower already owns 14 cannabis licenses in California for recreational and medical cannabis cultivation, manufacturing, distribution, retail and delivery. Activating all these licenses could be a jackpot for the company, driving revenues while minimizing risk.

Expansion into Canada with the acquisition of City Cannabis is the next step in Wildflower’s global strategy. The thriving retail outlet, with licenses for several more locations, provides Wildflower with a high-profile presence in what may be one of the greatest growth markets in the world. Wildflower plans to market its enormously successful products through the outlet and launch into the over-the-counter market with its CBD formulations and accessories.

An Expanding Footprint

Wildflower’s U.S. footprint currently encompasses more than 200 retailers in Washington state and more than 20 retailers in New York City. The company partnered with Retail Worx to establish shop-in-shop retail locations in the nucleus of New York and open its first Wildflower by Bridges General store.

The obvious next step for Wildflower in this partnership is a rollout into other Bridges General’s stores in New York City and San Francisco. Retail distribution in other major U.S. markets includes over 80 wellness and healthcare practitioners and an army of retail stores nationwide numbering more than 300. Wildflower is aggressively expanding both brand recognition and retail reach.

Wildflower continues to capture ever-greater market share with innovation, retail expansion and its growing family of popular brands. The company’s strategic partnerships, acquisitions and organic growth are all bolstered by the company’s marketing genius focused on locking in loyal consumers.

Grabbing national and celebrity attention, Wildflower used ingenious product placement during the 2019 Oscars by including its CBD+ Healing Stick in each of the gift bags of the stars, and Hollywood is embracing the product.

But Wildflower didn’t stop with the stars. To expand exposure into a new target audience, Wildflower launched an infomercial campaign in Phoenix promoting the company’s Wellness’ Cool Stick. And across the country, the company has employed an innovative pop-up store technique in SoHo, New York, to introduce its Wildflower Wellness products. To make this happen, Wildflower identified a compatible high-profile retail venue and struck a deal with the outlet, then marketed its products with fanfare in the upscale establishment for a limited time period, raising market uptake and visibility.

Wildflower is on a mission to create a global cannabis enterprise. With such rapid expansion of brand recognition and retail distribution, Wildflower is carving out its slice of the cannabis bonanza.

Buying Up Cannabis

And Wildflower isn’t alone in focusing on the booming cannabis business. Several market leaders have announced recent moves designed to strengthen their positions in the sector.

Tilray Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation and distribution, has announced the closing of a definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc., the parent company of a licensed cultivator of cannabis. The acquisition boosts the company’s capacity to supply cannabis products across Canada. Natura’s facility will be renamed High Park Gardens and be used as an additional cultivation facility to serve the medical and adult-use market in Canada.

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) acquired AgriNextUSA. The acquisition will accelerate Canopy Growth’s entry into key American jurisdictions. “The United States is the next stop on Canopy Growth’s desired path to becoming a leading, revenue-generating company focused on all aspects of cannabinoids and their potential,” said Bruce Linton, co-CEO and Chairman of Canopy Growth.

Medmen Enterprises Inc. (OTCQX: MMNFF) (CSE: MMEN) recently purchased two vertically integrated operations, which include both retail locations and 25,000 square feet of cultivation and production capacity. The company paid a combination of cash and stock valued at an aggregate of $33.5 million. With the closing of the acquisitions, MedMen will be licensed for three medical-use cannabis dispensaries in Arizona.

Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) completed the acquisition of Eureka, which operates a cultivation facility that is developing three dispensaries across California. Curaleaf has the largest footprint of single-branded retail stores in the United States. “The acquisition of Eureka cements our foundation in California and positions us well in the largest cannabis consumption market in the U.S.,” said Joseph Lusardi, CEO of Curaleaf.

Some have called the cannabis bonanza a once-in-a-generation opportunity and predict that this is simply the start of a decade-long cannabis bull market that’s only just begun. All indications suggest those predictions may be correct.

For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Hemp Boom Spawns Lucrative Deals

CannabisNewsWire Editorial Coverage: Ever since the Farm Bill was signed into law, farmers across the United States have rushed into hemp cultivation, driving demand for the supplies needed to grow the crop necessary to meet surging CBD use.

Global hemp industry to reach $22 billion in 2022.
CBD market could increase 40 times in the next four years.
Hemp farming skyrockets to meet demand.
Serious squeeze on hydroponic and cultivation supply products.

Hemp is booming across the country, and nowhere more so than in Kentucky, where the applications to grow hemp are expected to increase fivefold, and acreage dedicated to growing the crop is set to more than triple this year. At the forefront of this explosive market growth, Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) recently inked a strategic supply contract with Hempistry Inc., a leading Kentucky-based cultivator of high CBD content hemp. Since passage of the farm bill, other major Canadian producers have also been making deals to expand hemp and CBD operations south of the border. Tilray Inc. (NASDAQ: TLRY) announced the acquisition of a large hemp foods maker, and Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is making substantial investments in New York state. Aphria (NYSE: APHA) (TSX: APHA) temporarily withdrew from the U.S. market while fighting off a hostile takeover bid. And after a $1.8 billion investment from a U.S. tobacco giant, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is expanding globally with eyes to the U.S. markets in the future. Even the largest Canadian licensed producers are betting on hemp CBD, underscoring titanic market growth.

To view an infographic of this editorial, click here.

The Money Pump

In the course of only a few years, CBD extracted from hemp is now marketed for everything from pain relief and reducing inflammation to relieving stress and anxiety. CBD is sold in an array of products from shampoos, lotions and oils to drinks, pet treats and granola. The popularity of CBD isn’t likely to wane any time soon, and the soaring popularity is reflected in market projections.

The CBD boom was presaged by passage of the Farm Bill, an absolute sea change in the balance of power in global hemp markets. Historically, the United States had been an importer of hemp products, but now the U.S. market is expected to lead the global hemp industry reaching an eye-popping $22 billion in 2022. With a market expected to increase 40-fold in the next four years, it’s little wonder there’s such an enormous upsurge in hemp cultivation.

To achieve quality and consistency, much of the hemp cultivated in North America isn’t grown from seed but is cloned or propagated from existing hemp plants. Known as micropropagation, this process allows for a large number of plants to be readied simultaneously, facilitating stable, consistent production and guaranteeing that the plants are exact genetic copies of the most desirable mother plants. It’s exceptionally important in hemp cultivation to produce healthy, high-content CBD plants with all the characteristics required by hemp-product producers.

This process gives cultivators more control over how their plants grow and results in more valuable crops. The rapid vegetative propagation of plants under the controlled conditions of light intensity, temperature and precise nutrient mediums requires unique equipment and supplies. The nationwide surge in hemp production has created shortages and increased demand for these much-needed hydroponic supplies. With the boom in hemp cultivation occurring this planting season, many of the supplies required for successful micropropagation operations are in short supply. This supply squeeze has spawned an unprecedented industry opportunity.

The Right Moves

Identifying the upside early, Sugarmade Inc. (OTCQB: SGMD) has been making all the right moves to capture an outsized share of this burgeoning new market. A specialty product and brand marketing company, Sugarmade invests in and develops products and brands with disruptive potential.

Expanding its footprint in the supply of high-demand hydroponic and cultivation products, the company has been on an acquisition spree and executing new supply contracts to capture an ever-increasing market share. The latest supply contract with hemp cultivator Hempistry reflects Sugarmade’s hydroponic trajectory. Utilizing advanced plant genetics and technological innovation, Hempistry is now scaling operations to approximately 2,600 acres aggregated between its subsidiaries, while adding to the product value chain and enhancing production efficiencies.

To achieve these objectives requires a secure, reliable source of specialty equipment and supplies. Sugarmade recognized the potential windfall last year and locked in an option to invest $1 million in Hempistry. That relationship has blossomed into a supply agreement that should serve both companies extremely well. Hempistry is acquiring supplies for its hemp micropropagation operation from Sugarmade, and expectations are that this supply relationship will flourish as Hempistry expands operations domestically and internationally. The agreement will ensure supplies reach supply-starved Kentucky, which is on the leading-edge of the hemp cultivation boom.

“Industrial hemp is promising and is the fastest area of growth in Kentucky agriculture,” said Ryan Quarles, Kentucky commissioner of agriculture, in an interview with CNBC. “We don’t know if industrial hemp will replace tobacco, but we are going to champion it.”

Sugarmade CEO Jimmy Chan, now also a director at Hempistry, commented, “With at least 42,000 acres of hemp expected to be planted in Kentucky and considering an average plant density per acre of well over 1,000, farmers in Kentucky will need hundreds of millions of clones over the coming years. When these numbers are multiplied over the many other hemp cultivation states, it is easy for anyone to see the strong demand scenario that is quickly developing. We have already received our first shipments of micropropagation supplies, and we are in process of making deliveries. Sugarmade plans to significantly expand our operations relative to hemp cultivation.”

E Pluribus Unum

Out of many, one. The Latin phrase emblazoned on U.S. currency should be the slogan for what’s happening in the fractured and fragmented specialty hydroponic supply industry. With demand reaching epic proportions, the clutch of small and inefficient supply companies is ill prepared to service the requirements of the blooming hemp industry.

Cognizant of the shortfall, Sugarmade is on a mission to consolidate the fragmented industry by strategically acquiring other synergistic hemp-based operations. Sugarmade’s brands already include: Zenhydro.com, a comprehensive online hydroponics supply outlet; AthenaUnited.com, a specialist company providing hydroponic supplies to large commercial cultivators; CarryOutSupplies.com, a leader in paper and plastic supplies; and BudLife Cannabis Storage Solutions, which offers the world’s only patented intelligent packaging, storage and distribution for medicinal plants.

Continuing its consolidation strategy, Sugarmade recently announced that it will acquire the flagship operation of Washington State-based Hydro4Less, which is expected to produce about $5 million in revenues and be profitable this year. In the agreement, Sugarmade also gained an option to purchase two additional Hydro4Less retail operations, currently producing in excess of $20 million annually.

“Sugarmade is expecting to realize exceptional revenue growth this year from all of our hydroponic-related market sectors,” said Chan. “We are excited about having the very talented staff of Hydro4Less join the Sugarmade family of companies. We continue to seek additional acquisitions to further boost our already expected robust revenue growth rate.”

Expanding on a 2017 master marketing agreement with Bizright LLC where Sugarmade would sell its products, Sugarmade also announced that it will acquire Bzrth Inc., a sister company of Bizright. These accretive acquisitions will make Sugarmade one of the largest publicly traded hydroponic supply companies in the world.

Northern Neighbors Look to Capitalize

In its most expensive acquisition to date, Canadian based Tilray Inc. (NASDAQ: TLRY) announced that it has agreed to purchase Manitoba Harvest for $317 million in cash and stock to bolster its thrust into the U.S. CBD product market. Manitoba Harvest claims to be the world’s largest hemp food maker. With operations around the globe, Tilray now expects to launch CBD-derived products in the United States as early as this summer.

Less than a month after the signing of the 2018 Farm Bill, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) announced plans to invest up to $150 million to establish its first U.S. production facility in New York state. The company plans to establish large-scale production capabilities focused on hemp extraction and product manufacturing. Canopy called its expansion into the United States “another example of the strategic advantage” last year’s $4 billion investment Constellation Brands provides the company.

Aphria (NYSE: APHA) (TSX: APHA) temporarily withdrew from the U.S. market while fighting off a $2 billion hostile takeover bid from U.S.-based Green Growth Brands. Aphria rejected the bid saying it was being undervalued. Located in the greenhouse capital of Canada, Aphria Inc. is one of world’s lowest cost producers.

With international production and distribution, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is committed to building disruptive intellectual property by advancing research, technology and product development. The Cronos Group is building a global network with partnerships, joint ventures, production and distribution spreading across five continents. Cronos Group is intent on building an iconic brand portfolio around the globe.

Evaluating what has transpired and the projections of what is to come, the hemp markets and affiliated products and services appear to be sectors that could offer incredible returns. With multiple contracts in place, several acquisitions completed with more pending and planned, plus immense opportunity ahead, Sugarmade is hotly pursuing its mission to be a dominant player in the hydroponic supply industry piece of that pie.

For more information on Sugarmade, visit Sugarmade, Inc. (OTCQB: SGMD)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Mainstream Acceptance, Strong Growth Adds to Growing CBD Market

CannabisNewsWire Editorial Coverage: The CBD market is experiencing explosive growth as a result of growing mainstream acceptance and strong leadership.

The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Several companies are responding to the growth by expanding operations. Canadian-based Tilray Inc. (NASDAQ: TLRY) is adding production capacity in both Canada and Europe. Aphria (NYSE: APHA) (TSX: APHA) is increasing its indoor grow operations. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is focusing its development efforts on projects in the United States. And Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is using a significant outside investment to make strategic growth plans.

To view an infographic of this editorial, click here.

Growing Goodness

The CBD market has seen tremendous growth in the past few years, seemingly coming out of nowhere to become a billion-dollar industry. This eye-popping growth has been fueled in large part by CBD’s potential for health and well-being, an area that many researchers are focusing on. Companies have leapt upon the opportunity to offer consumers the benefits associated with cannabis without some of the other issues regularly linked with the drug, including getting users high.

If the past few years have been fruitful, the future looks even brighter for CBD. Soaring sales, growing acceptance within mainstream sports, and the recognized influence of some of the major players within the broader cannabis industry all point to positive movement forward for CBD. And as companies overcome the challenges offered by distributing a previously obscure product to a broad market, the industry looks set to soar.

A Rising Global Market

The growth of the CBD market has so far come mostly out of North America, where the likes of health and wellness company Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) have launched a variety of compelling CBD products. This geographical growth is rooted mostly in legal status, as CBD is extracted either from cannabis or from its nonhigh-inducing form hemp. Though legalization of cannabis remains variable in the United States, hemp is now legal at a national level in both the United States and Canada, with cannabis growth widely permitted.

As a result, the North American cannabis — including CBD — market, has grown in spectacular fashion. The market was worth $9.2 billion in 2017, and estimates project those numbers to reach $47.3 billion by 2027. Savvy companies, such as Wildflower Brands, are paying attention and taking action.

The European CBD market has seen less expansive growth. Within the EU, the range of processed products that can be made incorporating cannabis is more limited, and there’s been less of a concerted push towards legalization for both CBD and cannabis products. Consequently, market growth there has been less impressive.

But that may be about to change, according to analysis from market intelligence firm the Brightfield Group. The company recently predicted 400% growth in the European CBD market from 2018 to 2023, a massive rise in a short five-year span. It looks as if the CBD boom may be set to go global.

Sports and CBD

Cannabis prohibition isn’t the only thing shaping the CBD market. Society’s acceptance of cannabis and CBD cannot be overlooked as a contributing factor. The rules of entities not typically associated with cannabis have sometimes created obstacles to growth in the cannabis sector. But as the legal market develops, those institutions are shifting their attitudes as well.

The sports industry is an ideal illustration of this. During the war on drugs, many teams, leagues and professional organizations took a firm public stance against cannabis, laying down rules that prevented their players from indulging. The NFL, for example, has strict rules against cannabis consumption. Currently, however, former players are campaigning for a change to those rules, not just to allow players access to the same experiences as other people but to tackle issues specifically related to sports.

Recently, cannabis and CBD-infused products, including those such as Wildflower’s topical treatments, have provided a growing number of pain-treatment choices. Given the injuries so frequently seen in professional sports, pain management is crucial. Sports doctors, trainers, coaches and players are always on the lookout for the most effective treatment options. Currently the ban on cannabis and CBD restricts players from choosing such seemingly effective options, fueling the call for change.

Changes could also have a significant impact on the sponsorship side. Currently, only one professional sports team in the United States has a cannabis-related sponsorship, despite the growing wealth and influence of the industry. As barriers come down, the time may come for CBD, much like other recreational and medical products, to gain attention in the sport and beyond through sponsorship and supporter arrangements.

The Challenge of Delivery

This expansion doesn’t come without some challenges. As the market grows and evolves, CBD companies must find ways to distribute products to a sector that didn’t exist a decade ago. The infrastructure most other industries take for granted is being built from scratch.

Fortunately, the companies moving into this space are nimble and flexible, moving quickly to find solutions as they expand and grow. These solutions often include forming partnerships with other players within the cannabis sector to increase their combined reach. Wildflower has recently done this through a delivery fulfillment agreement with HelloMD, a leading digital healthcare platform for cannabis doctors, consumers and brands. The deal will allow Wildflower to potentially reach more customers through HelloMD’s expansive e-commerce platform.

Such moves should increase opportunities for CBD businesses to accelerate their expansion and reach a broader customer base, reversing years of prohibition. These partnerships may not only boost individual businesses but also add to the rising tide of CBD.

Cannabis Leaders Emerge

Celebrated leaders are starting to emerge at the head of the cannabis industry. Some have come from outside, their fame drawing attention to the industry. Others have come from within.

A recent list of the top 100 figures in the industry includes actor Jim Belushi, former Mexican president Vicente Fox and retired boxer Mike Tyson. The list also includes cannabis executives such as Terry Booth of Aurora and Elizabeth Hogan of GCH.

Wildflower Brands CEO William MacLean was included in the list, thanks to his hands-on approach to sales and marketing. His extensive travels to hospitals in North America have also given him insight into patient experience and the benefits that cannabis and CBD can offer. Combined with years of marketing experience, this impressive background puts MacLean in a strong position to market his brand and build teams of skilled experts for ongoing growth.

Cannabis Companies Reach New Highs

As the cannabis sector expands, many companies are going through periods of growth and rising revenues. Over the past few years, this rocketing trajectory has allowed the cannabis sector to diversify in interesting ways.

Based in Canada, Tilray Inc. (NASDAQ: TLRY) is looking to expand through acquisitions. The company recently acquired the largest hemp foods company in the world — Manitoba Harvest — to strengthen its foothold in the exploding hemp market. The company is also making other strategic growth and development moves, including moving into Europe.

Aphria (NYSE: APHA) (TSX: APHA) recently received a license amendment to expand its growing space. Headquartered in Leamington, Ontario, Aphria is working to set the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Aphria is committed to bringing breakthrough innovation to the global cannabis market and has a presence in more than 10 countries across 5 continents.

One of the large Canadian cannabis companies, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is looking to expand in the United States following the passing of the 2018 farm bill. Canopy is building a hemp-production facility in New York state and acquired hemp enterprise AgriNextUSA, moves that position the company to make the most of America’s swing towards hemp and become a leading player as the market heats up across North America. Canopy Growth boasts an extensive range of licenses and distribution deals north of the border, giving it a strong base from which to build its U.S. business.

The Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) recently closed a deal with outside company Altria, providing that company with a way into the hemp space. The C$2.4 billion strategic growth investment will provide Cronos with essential resources to expand during its critical phase of market growth in the United States.

With scientific and business innovation being led by a raft of far-sighted and innovative pioneers, the cannabis and CBD industries look set for another decade of incredible growth.

For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Hemp Market Drives Hydroponics Growth

CannabisNewsWire Editorial Coverage: A surge in hemp production means big business for hydroponic suppliers.

Hemp production set to massively increase in the United States this year.
Increased production driving high demand for hydroponic supplies.
Hydroponics companies are responding with expansion and acquisitions.

Sugarmade Inc. (OTC: SGMD) (SGMD Profile) has strategically acquired several companies to meet demand and expand its foothold. Canadian-based Tilray Inc. (NASDAQ: TLRY) has expanded production in both Canada and Europe while Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is developing projects in the United States, and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received massive outside investment to fuel its growth. Companies such as Aphria (NYSE: APHA) (TSX: APHA) are enlarging their indoor grow operations as they too rush to meet demand.

To view an infographic of this editorial, click here.

Hemp Bonanza

The legalization of hemp in the United States has ignited further growth in a massive new industry. Already under development through state laws and federally approved test sites, this historically valuable cash crop is now legal for cultivation across the country. With demand for CBD soaring, growers are scrambling to capitalize on an unprecedented opportunity.

However, sudden growth means a sudden need for supplies, skills and experience, none of which can be conjured from thin air. Obtaining these creates challenges for growers and opportunities for suppliers, and the match between those two varies across the map. As the hemp rush unfolds, some are doing better than others at rising to the challenges of hemp farming.

Challenges for the Hemp Industry

December 2018 saw the passing of the 2018 U.S. Farm Bill and with it the legalization of hemp cultivation in the United States. While the crop had previously been cultivated on test sites and through state-level laws, this was the first time in a century that this once-important cash crop was officially allowed by the U.S. government again. The move has created a whole new playing field, thrusting Sugarmade Inc. (OTC: SGMD) into the spotlight.

Sugarmade is a hydroponics supply company catering to the hemp market. As such, it has seen an extraordinary few years of growth. Even before the Farm Bill, the hemp industry had been growing. CBD, an active ingredient extracted from hemp, has become an incredibly popular product in the last few years. The plant is used in foods, oils, vaping fluid, drinks and health treatments. Research indicating its potential to support health and well-being has fueled consumer interest. The existing producers of hemp have seen profits soar, and now that the floodgates have opened, other businesses are rushing to get in on the act.

This creates massive challenges both for the industry and for individual businesses. Though hemp is now legal, it is tightly controlled, and producers must be able to grow hemp in accordance with strict rules, as well as to validate that both their facilities and their products meet these standards. That means employing skilled staff and using high-quality equipment.

The challenge of obtaining that equipment is made all the greater by the sudden and widespread nature of the expansion. Scores of companies all looking for equipment at once puts pressure on suppliers. If they have the supplies and the reach to widely distribute those supplies, then there’s a huge opportunity for growth. If they don’t, they’ll struggle to meet customer demand.

The struggle to meet that demand is likely to create a situation of haves and have-nots, in which some growers are able to expand while others fail to fulfil their objectives. Who succeeds and who fails will be decided to a large extent by who can find a reliable hydroponic supplier.

Equipping Growers

Despite the romantic image of farmers turning over a patch of land to a new crop, most hemp farming occurs indoors using hydroponic systems. That’s why companies such as Sugarmade are such a critical link in the hemp-farming process.

The hydroponic equipment needed to grow consistent high-grade hemp is varied and complex. A broad range of lighting equipment is needed to control photosynthesis. Specialized nutrient mixes provide plants the food they need to grow. And measurement solutions and environmental controls are necessary for staff to measure, monitor and control the myriad of factors that determine the quality, strength and health of the plants.

Given the circumstances, companies with expertise in hydroponics are imperative to provide supplies, but due to the previously restricted market, they’ve been relatively small. All that is changing in the rush to meet the needs of the burgeoning hemp market. Larger companies are desperately needed, and Sugarmade appears set to become one of those companies.

Sugarmade’s strategic intent is growth on two fronts, organically by brand expansion and through acquisitions. The company has a few deals in the pipeline that are pending audit and funding.

“Sugarmade plans to integrate these businesses fully as soon as is possible, making us one of the larger suppliers to this growing marketplace,” said Jimmy Chan, CEO of Sugarmade. “Additionally, we are in the process of vetting other possible acquisitions to further enhance the portfolio of hydroponic and cultivation supply products. We are certainly excited about our prospects for the remaining part of this year and into next year.”

The Local Picture

Even with such bold moves, it’s not possible for a company to expand everywhere at once, and hydroponic suppliers must choose where to focus. A focus on states with a strong presence in hemp is a good way to ensure a large market for supplies.

One area that’s rich in potential is Kentucky. A state with a strong history of tobacco growing, Kentucky is facing the reality that people are moving away from smoking. Hemp offers an alternative cash crop that some of the state’s farmers have been quick to leap upon. Approximately 16,000 acres of hemp were planted in Kentucky last year, and this is expected to nearly triple to 42,000 acres in 2019. The state has already received five times more applications to grow hemp this year than last. Sugarmade is catering to this boom through a supply agreement with Kentucky-based Hempistry Inc., which will help Hempistry achieve the nearly tenfold increase in hemp growing it has planned this year.

Sugarmade is also developing strong distribution channels in California, one of the first states to change its laws and embrace the rise of hemp. California’s large population and positive attitude towards CBD and hemp makes it another prime target for expansion.

By becoming an integral link in hemp production in these high-production states, Sugarmade grows organically by brand expansion, locks in revenues and is positioned to capture an outsized market share across the United States.

Competition Heats Up

The rapid rise of hemp and hemp-related markets has meant that a growing number of companies are jockeying for position in the hemp and CBD sectors, and some of them are seeing serious expansion.

Tilray Inc. (NASDAQ: TLRY), a Canadian company, has been expanding through acquisitions. The company recently acquired Manitoba Harvest, the largest hemp foods company in the world, to give it a position in a strategically important portion of the hemp market. This comes alongside other initiatives such as a move into Europe. These strategic moves have won praise for Tilray’s leadership team.

Another Canadian company and one of the largest in the sector, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is making strong moves to expand south in the wake of the Farm Bill. It has established a hemp-production facility in New York state and acquired hemp enterprise AgriNextUSA. This allows the company to make the most of America’s swing towards hemp and work to become a leading player as the market heats up across North America. Canopy Growth already has an extensive range of licenses and distribution deals north of the border, giving it a strong base from which to build its U.S. business.

The excitement around hemp has drawn interest from companies outside the sector. Altria, the tobacco giant behind the Marlboro brand, is looking to expand its opportunities as tobacco faces ongoing challenges. Like many Kentucky farmers, Altria is looking to hemp and related products for potential solutions. It recently closed a deal to invest C$2.4 billion in Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), providing Altria with a way into the hemp sector. The funds will give Cronos resources to expand during this critical phase of market growth in the States.

In testament to value, Aphria (NYSE: APHA) (TSX: APHA) is fending off a hostile takeover by Green Growth Brands. In addition, Aphria recently received a license amendment to expand its growing space, which makes it an appealing prospect for other companies looking to increase their capacity.

The hemp bonanza has just begun. Like every new market, shakeouts and consolidations are bound to happen. The strong will survive while the weak will fail. The same holds true for the hydroponic suppliers. Given the circumstances, it’s inconceivable that many small suppliers will survive. The victors will be those who can get to markets early and scale through agreements and acquisitions. Sugarmade is making all the right moves to not just survive but also thrive.

For more information on Sugarmade, visit Sugarmade, Inc. (OTCQB: SGMD)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

CBD Surges into Mainstream with New Products, Celebrity Endorsements and Emerging Consensus about Benefits

CannabisNewsWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

Growing CBD market could eclipse broader cannabis market
Consensus about health benefits backed by clinical work, personal endorsements lead to heightened interest
CBD found in vast array of new products

As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile). Canadian company Tilray Inc. (NASDAQ: TLRY) is riding the wave by acquiring Manitoba Harvest, the world’s largest hemp foods company. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) recently announced it has closed a billion-dollar equity investment from an outside company. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) just received a cultivation license from Health Canada for its facility in New Brunswick. Aphria (NYSE: APHA) (TSX: APHA) also received additional licensing approval from Health Canada, permitting the company to commence production in an additional 800,000 square feet of facilities.

To view an infographic of this editorial, click here.

An Established Wellness Ingredient Goes Mainstream

The recent passage of the Hemp Farming Act in the 2018 U.S. farm bill made hemp an ordinary agricultural commodity, swinging open the door for hemp-derived CBD. The industry is seeing everyone from A-list celebs at the Oscars to noted medical professionals such as American neurosurgeon Dr. Sanjay Gupta extolling the therapeutic benefits of CBD.

Already incorporated into to a wide variety of functional foods and beverages, CBD has also started to show up in coffee and cocktails, with specialty CBD drinks joining the menus at bars and coffee shops across America. Many users swear by the efficacy of CBD to combat ailments such as anxiety, sleeplessness or physical pain.

With mounting therapeutic credence and a raft of celebrity endorsements, its little wonder that CBD has exploded into the mainstream. Product developers have been scrambling to incorporate cannabidiol into every kind of consumer product imaginable, from health and beauty items for the skin to tasty treats for the family pet. The accumulating evidence for CBD’s health benefits also owes a great deal to watershed achievements such as Epidiolex, a CBD-derived anti-seizure medication that has been through numerous clinical trials, becoming the first FDA approved cannabis-based drug utilized to treat severe forms of childhood epilepsy.

There’s an emerging consensus among consumers that CBD has broad ranging medicinal benefits with the ability to treat something as serious as epilepsy yet also safe enough to be used for daily aches and pains or address a myriad of anxieties and ailments. This awareness, combined with the rapid proliferation of CBD consumer products ranging from vape pens to functional foods, has led to a veritable grassroots market revolution.

Any lingering stigma or confusion between CBD and THC is rapidly eroding, particularly with the likes of homemaking legend Martha Stewart now providing her knowledge of consumer products to CBD developers. And household names such as Kim Kardashian, Olivia Wilde and Jennifer Aniston are also going on record as having enjoyed the health benefits associated with their personal consumption of CBD products.

Growing Consensus about Healing Power of Plants

Grabbing A-list celebrity attention, the Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) CBD+ Healing Stick was in each of the gift bags of the stars during Oscar weekend 2019. Packing 500mg of highly concentrated, full-spectrum CBD, Wildflower’s cooling and soothing stick is easy to apply for targeted pain relief and skin care, providing relief through a unique CBD blend that includes therapeutic ingredients such as arnica, wintergreen and other essential oils.

An established, respected brand, Wildflower Wellness’s overriding mission is to connect people to the healing power of plants via the company’s increasingly sophisticated line of CBD vaporizers, capsules, tinctures, soaps and topicals – formulating its extracts with essential amino acids and beneficial terpenes, the organic compounds that provide flavor and scent. A testament to the popularity of Wildflowers’ proprietary formulations can be found in a NY Magazine article “The Best CBD and Hemp Products for the Tasteful Non-Stoner” touting the company’s CBD Immunity Vaporizer, stating that, “Wildflower also made the perfect CBD starter kit…”

The company’s products are made in the United States at Wildflower’s GMP facilities, third-party lab tested and backed by a 100 percent satisfaction guarantee. Wildflower’s well-formulated, convenient and consumer conscious products such as its disposable ACHES CBD+ vaporizer are increasingly enjoying widespread acceptance, in part due to education of the consumers by cannabis and wellness influencers.

Flexing its branding and marketing muscle, Wildflower Wellness partnered with Bridges General to take that company’s reimagined convenience store concept to the next level. The partnership fuses together the immense popularity of the Bridges General design-centric retail space that delivers convenience for the on-the-go urban professional with an engaging opportunity to experience and learn about the benefits of CBD. The partnership is already serving some of the most powerful and influential people in the country at its Lower Manhattan store, as well its Madison Avenue Bridges General store. Further expanding reach, Wildflower has also engaged Retail Worx to establish shop-in-shop retail availability at more than 20 locations in the heart of New York City’s booming cannabis market.

Industry Seeing Retail Renaissance in Consumer Products

Wildflower continues to expand its impressive retail reach, with the Wildflower Wellness brand already enjoying distribution in key states, such as Washington at more than 200 retailers. The company’s California-based King Extracts brand is focused on cannabis technology and delivery systems. The company’s King Extracts product, the King Recharge, is a discreet but powerful little pocket vaporizer that comes in its own sleek charging and storage case, which has room for two 500mg cartridges and a backup battery.

King Recharge offers fractionally distilled CO2 extractions in exceptionally clean and sophisticated blends that utilize proprietary terpenes in order to deliver a full, robust flavor profile. Sativa, Indica and Hybrid, as well as two limited-edition Sativa flavors (watermelon and bubble gum), are currently available. Additionally, Wildflower’s growing national distribution arm includes over 80 other wellness and healthcare practitioners, bringing the company’s total to some 300-plus stores nationwide.

The company has even branched out into physical retail itself, harnessing the power of increasing brand recognition, a firm footing in the California market and tightly knit relationships with local hospital oncology departments and community programs. Wildflower has launched its own dispensary in Los Angeles and provides on-demand, legal and licensed cannabis delivery services to adults in the L.A. area. The second quarter of 2019 saw the 10th consecutive quarter of increased revenue for Wildflower, with $1.4 million in sales underscoring a burgeoning direct-to-consumer online channel that witnessed 300 percent growth last year alone.

Many analysts are saying that the CBD rush is just getting started. One recent estimate indicates that the CBD market alone could eclipse the entire remainder of the cannabis market combined. Wildflower is making all the right moves to capture an outsized share of the CBD bonanza.

A Rising Tide Lifts All Boats

Other companies are recognizing the potential profit CBD may provide. Canadian company Tilray Inc. (NASDAQ: TLRY) just finalized its acquisition of Manitoba Harvest, a move Tilray president and CEO called a milestone for the cannabis industry. “It builds on the strategic partnerships we have formed with consumer brand industry leaders and demonstrates our track record of disrupting the global pharmaceutical, alcohol, CPG, and functional food and beverage categories,” said Brendan Kennedy. The deal gives Tilray access to a broad portfolio of food products that are distributed in 16,000 stores across the United States and Canada, as well as the opportunity to expand beyond the food category, possibly including extracts.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) just closed a C$2.4 billion investment from Altria, the American company behind brands such as Marlboro and Benson & Hedges. The move is a sign of the huge interest the CBD market is generating from companies both in and outside the industry. Cronos operates two wholly owned, Canadian-licensed producers and has multiple international production and distribution platforms and partnerships across five continents. Cronos intends to continue to expand its global footprint as it focuses on building an international iconic brand portfolio and developing disruptive intellectual property. The company is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) predicts the new facility in Fredericton, New Brunswick, will produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months. In addition, the company expects to create more than 130 jobs at the plant. “New Brunswick has emerged as a leader in the legal cannabis sector, and the province is an excellent place to do business,” said co-CEO and Canopy Growth chairman Bruce Linton. “We will leverage our existing operational expertise to ensure we support the needs of our customers while making a meaningful contribution to the local economy primarily through new job creation.”

As part of its Part IV and Part V expansions, Aphria (NYSE: APHA) (TSX: APHA) is increasing production at its Aphria One location. The expansions brig industry-leading automation to the company. While critical phases such as initial cuttings, trimming and pruning mature plants will be performed by hand, the in-house designed technology will automate key steps, including transplanting cuttings, transplanting plans through harvesting, de-budding and rough trimming, drying and curing, and waste disposal.

With the 2018 Farm Bill thrusting hemp-derived CBD into the limelight, the broader industry likely stands to experience a rising tide that will lift all boats.

For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Hydroponic Supplies Play Key Role in Hemp Market Growth

CannabisNewsWire Editorial Coverage: Surging hemp market growth has created huge demand for hydroponic supplies.

Demand for CBD is driving a rise in hemp cultivation, much of which is done indoors using hydroponic equipment.
This hydroponic approach allows greater quality control over the cultivation process and the hemp.
Acquisitions and expansion are needed for hydroponic companies to keep up with demand.

Hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has been making swift moves to deal with this demand, acquiring other supply companies and outlets. Canadian company Tilray Inc. (NASDAQ: TLRY) has acquired the world’s largest hemp foods company, giving it a strong position in a customer-facing part of the sector. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has set up a new hemp-growing facility in New York state, using hydroponics to help it meet growing demand. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a large boost in investment thanks to interest in the surrounding sector, providing fuel for future growth. Aphria (NYSE: APHA) (TSX: APHA) is looking beyond North America, with the acquisition of a European distributor.

To view an infographic of this editorial, click here.

A Better Way to Grow Hemp

With the passing of the Farm Bill in December, the production of hemp for CBD, which was already on the rise, looks set to soar in the United States and beyond. Demand for CBD for health and wellness products keeps rising as more research focuses on its potential for relaxation, pain management and other benefits for living a healthy life. Farmers are grabbing the opportunity to invest in a new cash crop, one which has provided remarkable returns for some.

But all this attention on hemp and CBD brings challenges with it. This is a tightly regulated sector with demanding customers. High-quality crops are essential for success, and managing both quality and consistency can prove incredibly challenging. To do this, many growers are turning to hydroponics.

Hydroponics and Hemp

Hydroponic equipment offers an alternative approach from growing plants in soil. Instead, the hemp harvest is grown in solutions rich with sustaining minerals, with roots either suspended directly in the liquid or supported by a medium like gravel that the liquid can move through. Provided by specialist companies such as Sugarmade Inc. (OTCQB: SGMD), hydroponic systems give growers more control over how their plants grow.

This approach can help hemp growers in a number of ways. The most obvious benefits revolve around the fact that the plants are grown in clean, indoor environments. While this results in higher costs compared with growing in fields, it also results in a number of benefits. Plants are safe from changes in the weather that can be harmful to many crops, such as sudden frosts or unseasonal heat. They’re also protected from contaminants, both living and inanimate, and from infections that could kill the plants to chemicals carried in the atmosphere that could taint the eventual crop.

While any indoor growing situation can help with this, hydroponics brings greater advantages. By feeding plants with carefully balanced nutrient baths instead of soil and fertilizer, farmers gain more control over the crops they produce. This means higher CBD content, making their plants more valuable. Hydroponics also means that the hemp often more easily passes the stringent quality tests that are applied to plants in this sector, tests that are likely to become even firmer now that the federal government is officially allowing and regulating hemp production in the United States.

As a result, companies such as Sugarmade are on the brink of a potential new gold rush. With some companies moving into the CBD market and others rushing to expand their existing hemp production, demand for hydroponic supplies is on the rise.

Acquiring Influence

This has created a great opportunity for hydroponic suppliers, and some are moving to further strengthen their position. Those with an eye to the future, such as Sugarmade, were making preparations long before the Farm Bill passed into law. Now they’re reaping the benefits of that forward thinking.

As with hemp production, consistency is key to the supply of hydroponic equipment. Customers are reliant on these companies not only for setting up their growing spaces but for expanding them, maintaining and replacing equipment, and ensuring a steady supply of the minerals needed to feed the plants. A company that can’t provide consistent supplies will struggle to maintain relationships with its customers, whose crops rely on that supply line. With demand growing, it’s harder to ensure supplies, and for many, the answer is expansion.

This is the approach that Sugarmade is taking. The company has made an agreement to acquire Sky Unlimited LLC, a California-based distributor of cultivation supplies. This will allow Sugarmade to meet more demand than it has previously faced, and so cope with the increased needs of customers.

“This year, Sky Unlimited and its associated operations are expected to produce in excess of $40 million in revenues with profitability and positive cash flow,” Jimmy Chan, CEO of Sugarmade,said in late 2018. “This new revenue stream combined with our recently upwardly guided revenue forecast of $30 million for next year will make Sugarmade one of the largest publicly traded suppliers to the booming cannabis cultivation marketplace, with a combined revenue forecast for next year in excess of $70 million.”

There’s also an opportunity for expansion, given the huge market growth. Sugarmade has leapt upon this chance through its possible acquisition of a retail location from Washington State-based company Hydro4Less and options to purchase two more. The first location alone is expected to provide $5 million in revenue, as Sugarmade increases its foothold in the hydroponic market.

Hydroponics Beyond North America

While the current focus for hemp and CBD, as well as the associated part of the hydroponics market, is currently on the North America, there is also important potential for growth further afield. European countries are showing an increasing interest in CBD products, with customers keen to buy in, and some governments re-examining the legislation around these crops. For fast-moving companies, there’s a chance to get in on the ground floor of the next wave of hemp hydroponics.

Sugarmade is ahead of the game in this area. Last summer, the company made its first sales into Europe, establishing a place in the continent’s supply chain. European customers have been taking an increasing interest in the quality products and attractive prices provided by American hydroponic companies, and Sugarmade is making the most of it.

“The lack of available products within the European markets provides Sugarmade additional revenue growth opportunities,” Chan said. “We view this as a potential growth market for Sugarmade especially considering there are more than 740 million people in Europe compared to only about 360 million in the U.S. We believe even a few points of market share of this huge market will have a very positive effect on our growth rate.”

Companies Race for Hemp Dominance

Like Sugarmade, Canadian company Tilray Inc. (NASDAQ: TLRY) has been using acquisitions to strengthen its place in the hemp and adjacent markets. One of the most significant is the recent acquisition of Manitoba Harvest, the world’s largest hemp foods company. Food and drink are increasingly important parts of the hemp market, as customers look for hemp-based whole foods and tasty ways to consume CBD. With a range of products including oils, granola, and protein powder that are sold in more than 16,000 major retailers, Manitoba Harvest gives Tilray a powerful place in this sector.

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is one of the largest companies working in hemp, thanks to its steady growth paired with billions of dollars in outside investment. The company is in the process of expanding from Canada into the United States, with the establishment of a hemp production facility in New York state. Growth into the States will allow Canopy Growth to benefit from this year’s CBD surge. The company is also working to raise the public profile and usefulness of CBD through research with the NHL on using CBD to treat concussions.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), one of the big companies making use of hydroponic equipment, has benefited hugely from outside interest in the market. Less than a month ago, it closed a C$2.4 billion investment from Altria, the American company behind brands such as Marlboro and Benson & Hedges. It’s a sign of the big money currently swirling around this part of the economy, a large part of which is invested in crops and the equipment to grow them.

Some of this big money was recently directed into an attempted hostile takeover of Aphria (NYSE: APHA) (TSX: APHA) by Green Growth Brands. It was a move that showed the high value placed on companies such as Aphria, even as the company’s board shot down the bid. Like Sugarmade, Aphria has been making moves beyond North America and into Europe, with the acquisition of a German distributor.

The hemp and CBD market keeps growing, more money keeps flooding in, and a large part of it will inevitably be funneled into hydroponics to create plants that meet the standards demanded by customers and regulators. For both CBD companies and hydroponic suppliers, that’s great news.

For more information on Sugarmade, visit Sugarmade, Inc. (OTCQB: SGMD)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.